Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
20.11.2026
Learn why MPs accused Motsoaledi of failing to act against officials linked to the R15bn antiretroviral tender set aside by the High Court last month.
Latest
More news
16.11.2026
Learn what the WHO's latest estimates reveal about TB in South Africa, including 235,000 new cases, 53,000 deaths and persistent diagnosis gaps.
15.11.2026
Learn why the state wants the Constitutional Court to allow treatment instead of lump-sum payouts in medical negligence cases, and why critics object.
15.11.2026
Understand the challenges of mental health underwriting in life insurance and why insurers must adapt to new realities.
13.11.2026
Aspen share buybacks total R2.43bn as the Ovestin sale releases capital. Explore the earnings outlook and concerns over losing a high-margin product.
13.11.2026
Life Healthcare's trading statement reveals higher normalised earnings, lower HEPS and the impact of a scheme under curatorship.
12.11.2026
Aspen wins generic semaglutide approval in South Africa and Brazil, with launches planned in coming months. Read what this means for diabetes care.
12.11.2026
Learn why the Diabetes Alliance is launching a framework to track diabetes care commitments as South Africa's 2027 NCD targets rapidly approach.
12.11.2026
Learn why Viatris and Innovata are seeking leave to appeal the ARV tender ruling that set aside their TLD contracts, and what it means for supply.
11.11.2026
Public medicine shortages leave patients without treatment as unpaid provincial bills disrupt supplies. Read why financial accountability matters.
10.11.2026
The FDA orders GLP-1 eye risk warnings for diabetes and weight-loss medicines after reviewing NAION evidence. Read what the changes mean for care.
08.11.2026
The Xtandi patent dispute reaches South Africa’s Constitutional Court on 23 November. Read what is at stake for generic access and damages claims.
06.11.2026
Pharmaceutical sovereignty is back in focus as Ebola spreads in the DRC. See how pooled procurement and shared regulation could secure supplies.
Free every Friday
Health Matters Weekly
Not ready to subscribe? Get the week’s most important Southern African healthcare stories, with what they mean for the industry, in one free email.
The archive
Browse every Health Matters article by month.